Picture of Bavarian Nordic A/S logo

BAVA Bavarian Nordic A/S News Story

0.000.00%
dk flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Bavarian Nordic drops 10% after earnings guidance comes short

** Shares in Bavarian Nordic  BAVA.CO  slump around 10%
after the Danish vaccine maker announced 2025 earnings guidance
below expectations 
        ** The company sees 2025 revenue in the range of 5.7-6.7
billion Danish crowns vs an LSEG estimate of 6.42 billion and
expects EBITDA margin of 26%-30%
  
    ** It also flagged that revenue and EBITDA will vary
throughout the year, with first quarter of 2025 being light
    ** Kempen Life Sciences Research says the revenue guidance
is in line with consensus, but EBITDA outlook came in below
    **  The stock falls to its lowest since November and is
among top losers on Europe-wide STOXX 600  .STOXX  index
    
    
    


 (Reporting by Vera Dvorakova)
 ((vera.dvorakova@thomsonreuters.com))

Recent news on Bavarian Nordic A/S

See all news